Inspirion Wealth Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Inspirion Wealth Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10,000	Closed	-$24.3K	–	189
2026 Q2	$24.3K	Hold	10,000	–	–	﹤0.01%	187
2026 Q1	$16.9K	Hold	10,000	–	–	﹤0.01%	180
2025 Q4	$51.8K	Buy	+10,000	New	+$51.4K	0.01%	168
2025 Q3	–	Sell	-10,000	Closed	-$38.3K	–	152
2025 Q2	$38.3K	Buy	+10,000	New	+$25.9K	0.01%	157

Other funds holding ALDX

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Inspirion Wealth Advisors's ALDX Position: Q3 2026 in Review

Inspirion Wealth Advisors sold out of Aldeyra Therapeutics (ALDX) in Q3 2026, closing a stake of 10,000 shares — an estimated $24.3K sold.

Inspirion Wealth Advisors first reported a position in ALDX in Q2 2025 and held it in 4 quarters. The position peaked at $51.8K in Q4 2025. 2 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.

Inspirion Wealth Advisors reported no remaining Aldeyra Therapeutics position as of Q3 2026 after selling out during the quarter.
Inspirion Wealth Advisors sold 10,000 Aldeyra Therapeutics shares in Q3 2026, an estimated $24.3K.
Inspirion Wealth Advisors first reported a position in Aldeyra Therapeutics in Q2 2025 and held it in 4 quarters.
Inspirion Wealth Advisors's Aldeyra Therapeutics position peaked at $51.8K in Q4 2025.
2 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.

Based on Inspirion Wealth Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.